Profile	GDS3514 / 219771_at
Title	Liposarcoma response to doxorubicin in vitro
Organism	Homo sapiens

Graph caption help

Sample	Title	Value	Rank
GSM325240	Patient no. 1: control	1249.39	76
GSM325241	Patient no. 1: treated	1482.7	80
GSM325242	Patient no. 9: control	338.373	51
GSM325243	Patient no. 9: treated	267.589	46
GSM325244	Patient no. 18: control	400.364	51
GSM325245	Patient no. 18: treated	252.667	40
GSM325246	Patient no. 12: control	121.089	33
GSM325247	Patient no. 12: treated	147.663	38
GSM325248	Patient no. 3: control	788.598	68
GSM325249	Patient no. 3: treated	1021.21	73
GSM325250	Patient no. 7: control	387.036	57
GSM325251	Patient no. 7: treated	382.385	58
GSM325252	Patient no. 15: control	575.932	61
GSM325253	Patient no. 15: treated	556.109	61
GSM325254	Patient no. 4: control	611.162	63
GSM325255	Patient no. 4: treated	687.492	65
GSM325256	Patient no. 19: control	162.788	37
GSM325257	Patient no. 19: treated	155.863	38
GSM325258	Patient no. 14: control	340.64	50
GSM325259	Patient no. 14: treated	294.072	43
GSM325260	Patient no. 13: control	95.9519	22
GSM325261	Patient no. 13: treated	234.756	37
GSM325262	Patient no. 17: control	317.222	47
GSM325263	Patient no. 17: treated	164.424	31
GSM325264	Patient no. 10: control	481.064	58
GSM325265	Patient no. 10: treated	242.736	42
GSM325266	Patient no. 5: control	462.954	58
GSM325267	Patient no. 5: treated	189.916	46
GSM325268	Patient no. 11: control	1247.87	77
GSM325269	Patient no. 11: treated	429.654	58
GSM325270	Patient no. 6: control	409.674	50
GSM325271	Patient no. 6: treated	160.12	37
GSM325272	Patient no. 8: control	1046.99	74
GSM325273	Patient no. 8: treated	76.2024	20
GSM325274	Patient no. 16: control	424.947	55
GSM325275	Patient no. 16: treated	278.81	48
GSM325276	Patient no. 2: control	1052.4	73
GSM325277	Patient no. 2: treated	485.687	62